ABOUT AbClon
Overview
History
Business Portfolio
Scientific Advisory
Contact Us
ÀÎÀç»ó
º¹¸®ÈÄ»ý/ä¿ëÀýÂ÷
ÀÔ»çÁö¿ø
TECHNOLOGY
Biosynergy Antibody
YPLUS
AffiMab
THERAPEUTIC ANTIBODY
Pipeline
Antibody Drug Industry
ANTIBODY SERVICE
INVESTORS
ÁÖ°¡Á¤º¸
°ø½ÃÁ¤º¸
½ÃÀ庸°í¼
NOTICE
Notice/News
¤ýHome > Community > Notice / News
Total:
111
, page:
3/8
81
¾ÛŬ·Ð, 140¾ï¿ø ±Ô¸ð Àüȯ¿ì¼±ÁÖ ¹ßÇàÇÏ¿© CAR-T ¼¾ÅÍ ±¸Ãà º»°ÝÈ
°ü¸®ÀÚ
2020-01-31
119
80
¾ÛŬ·Ð, ¹ÙÀÌ¿ÀÀ¯·´¿¡¼ ½Å¾à °³¹ß ÇöȲ ¹ßÇ¥
°ü¸®ÀÚ
2020-01-31
100
79
¾ÛŬ·Ð, ¼¿ï¾Æ»êº´¿ø ÅëÇØ ÀÓ»ó¿ë CAR-T Ä¡·áÁ¦ Á¦Á¶ °øÁ¤ È®¸³ ÁøÇà
°ü¸®ÀÚ
2020-01-31
81
78
À¯»óÁõÀÚ°áÁ¤(Á¦3ÀÚ¹èÁ¤)
°ü¸®ÀÚ
2019-11-14
417
77
¾ÛŬ·Ð, ±¹³» ÃÖ´ë CAR-T ¼¼Æ÷Ä¡·áÁ¦ »ý»ê¼¾ÅÍ ÃßÁø
°ü¸®ÀÚ
2019-07-15
721
76
¾ÛŬ·Ð, 2019 ¹ÙÀÌ¿ÀUSA ¼ Ç÷§Æû ±â¼ú ¹× ÁÖ¿ä ÆÄÀÌÇÁ¶óÀÎ ¼Ò°³
°ü¸®ÀÚ
2019-07-15
326
75
ÀüÀÚÁõ±Ç Àüȯ¿¡ µû¸¥ ÁÖÁÖ Á¶Ä¡»çÇ×
[1]
°ü¸®ÀÚ
2019-07-15
143
74
Á¦ 9 ±â °á»ê°ø°í
°ü¸®ÀÚ
2019-03-27
178
73
[¾Æ½Ã¾Æ°æÁ¦ 19.02.14] "¾ÛŬ·Ð, À¯¹æ¾Ï ñé 1»ó IND ½ÂÀΡ¦¿ÃÇØ ±â¼ú·á ±â¹Ý ½ÇÀû¹Ýµî ±â´ë"
°ü¸®ÀÚ
2019-02-18
360
72
[ÆÄÀ̳½¼È 19.02.13] ¾ÛŬ·Ð, À¯ÇѾçÇà°ú ½Å±Ô ¸é¿ªÇ×¾ÏÁ¦ Èĺ¸¹°Áú µµÃâ ¼º°ø
°ü¸®ÀÚ
2019-02-18
265
71
[ÀÌÅõµ¥ÀÌ 19.01.30] ¾ÛŬ·Ð, GC³ì½ÊÀÚ·¦¼¿ NK ¼¼Æ÷Ä¡·áÁ¦ °³¹ß¿¡ ÇÙ½É Ç×ü ±â¼ú ÀÌÀü
°ü¸®ÀÚ
2019-02-18
245
70
[¹ÙÀÌ¿ÀS 18.12.05] ¾ÛŬ·Ð, ³¼Ò¾Ï Ÿ±ê '½ºÀ§Ã³ºí CAR-T' ±¹Ã¥°úÁ¦ ¼±Á¤
°ü¸®ÀÚ
2019-02-18
147
69
¾ÛŬ·Ð, À§¾Ï°ú À¯¹æ¾Ï Ç×ü½Å¾à ±Û·Î¹ú ±â¼úÀÌÀü
°ü¸®ÀÚ
2018-11-06
363
68
À¯ÇѾçÇà°ú 'ÀÌÁßÇ×ü ¸é¿ªÇ×¾ÏÁ¦' °øµ¿°³¹ß °è¾à
°ü¸®ÀÚ
2018-06-27
448
67
Á¦ 8 ±â °á»ê°ø°í
°ü¸®ÀÚ
2018-03-29
359
1
2
3
4
5
6
7
8
Á¦¸ñ
³»¿ë
±Û¾´ÀÌ